These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 25893526)
1. Efficacy and Safety of Human Growth Hormone in Idiopathic Short Stature. Tao S; Li G; Wang Q; Hu Y Indian J Pediatr; 2015 Jul; 82(7):625-8. PubMed ID: 25893526 [TBL] [Abstract][Full Text] [Related]
2. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center. Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651 [TBL] [Abstract][Full Text] [Related]
3. Effects of different therapy regimens to increase final adult height in males at advanced bone age with idiopathic short stature. Wang W; Wang Y; Xiao Y; Cao N; Wang Y BMC Pediatr; 2023 Dec; 23(1):615. PubMed ID: 38053091 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of recombinant human growth hormone in treating Chinese children with idiopathic short stature. Ying YQ; Hou L; Liang Y; Wu W; Luo XP Growth Horm IGF Res; 2018; 42-43():80-85. PubMed ID: 30343148 [TBL] [Abstract][Full Text] [Related]
5. Effect of long-acting PEGylated growth hormone for catch-up growth in children with idiopathic short stature: a 2-year real-world retrospective cohort study. Xie L; Li Y; Zhang J; Guo S; Chen Q; Ma H; Jiang W Eur J Pediatr; 2024 Oct; 183(10):4531-4539. PubMed ID: 39158594 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of recombinant human growth hormone in children with different etiologies of dwarfism from a pharmacoeconomic point of view. Ma Y; Sheng J; Wang L; Zhang Y; Liu L Medicine (Baltimore); 2024 Jun; 103(25):e38350. PubMed ID: 38905369 [TBL] [Abstract][Full Text] [Related]
7. Safety of growth hormone treatment of children with idiopathic short stature: the US experience. Allen DB Horm Res Paediatr; 2011; 76 Suppl 3():45-7. PubMed ID: 21912165 [TBL] [Abstract][Full Text] [Related]
8. A pilot study of growth hormone administration in boys with predicted adult short stature and near-ending growth. Rothenbuhler A; Ormières B; Kalifa G; Bougnères P Growth Horm IGF Res; 2015 Apr; 25(2):96-102. PubMed ID: 25641639 [TBL] [Abstract][Full Text] [Related]
9. Relationship between vitamin D receptor (VDR) polymorphisms and the efficacy of recombinant human growth hormone (rhGH) treatment in children with idiopathic short stature. Wang W; Luo XP; Cai LX; Cui ZR; Luo XY; Luo RK Genet Mol Res; 2015 Sep; 14(3):10507-14. PubMed ID: 26400282 [TBL] [Abstract][Full Text] [Related]
10. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial. Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA; Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099 [TBL] [Abstract][Full Text] [Related]
11. The effect of treatment with recombinant human growth hormone (rhGH) on linear growth and adult height in children with idiopathic short stature (ISS): a systematic review and meta-analysis. Paltoglou G; Dimitropoulos I; Kourlaba G; Charmandari E J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1577-1588. PubMed ID: 33035189 [TBL] [Abstract][Full Text] [Related]
12. The effect of growth hormone treatment on height in children with idiopathic short stature. Jeong HR; Shim YS; Lee HS; Hwang JS J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):629-33. PubMed ID: 24810558 [TBL] [Abstract][Full Text] [Related]
13. A Real-World Study of Recombinant Human Growth Hormone in the Treatment of Idiopathic Short Stature and Growth Hormone Deficiency. Gou P; Cheng X; Leng J; Su N Ther Clin Risk Manag; 2022; 18():113-124. PubMed ID: 35342293 [TBL] [Abstract][Full Text] [Related]
14. Effect of long-term recombinant growth hormone therapy in children--the National Cooperative Growth Study, USA, 1985-1994. Root AW; Kemp SF; Rundle AC; Dana K; Attie KM J Pediatr Endocrinol Metab; 1998; 11(3):403-12. PubMed ID: 11517956 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy of different doses of recombinant human growth hormone in the treatment of short stature in children born small for gestational age]. Qie D; Yang F Zhongguo Dang Dai Er Ke Za Zhi; 2016 Mar; 18(3):247-53. PubMed ID: 26975824 [TBL] [Abstract][Full Text] [Related]
16. Near adult heights after growth hormone treatment in patients with idiopathic short stature or idiopathic growth hormone deficiency. Frindik JP; Kemp SF; Hunold JJ J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():607-12. PubMed ID: 12795361 [TBL] [Abstract][Full Text] [Related]
17. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group. Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518 [TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Pediatric Growth Hormone Therapy: Results From the Full KIGS Cohort. Maghnie M; Ranke MB; Geffner ME; Vlachopapadopoulou E; Ibáñez L; Carlsson M; Cutfield W; Rooman R; Gomez R; Wajnrajch MP; Linglart A; Stawerska R; Clayton PE; Darendeliler F; Hokken-Koelega ACS; Horikawa R; Tanaka T; Dörr HG; Albertsson-Wikland K; Polak M; Grimberg A J Clin Endocrinol Metab; 2022 Nov; 107(12):3287-3301. PubMed ID: 36102184 [TBL] [Abstract][Full Text] [Related]
19. Combined therapy with GnRH analogue and growth hormone increases adult height in children with short stature and normal pubertal onset. Li S; Wang X; Zhao Y; Ji W; Mao J; Nie M; Wu X Endocrine; 2020 Sep; 69(3):615-624. PubMed ID: 32533506 [TBL] [Abstract][Full Text] [Related]
20. Treatment of Short Stature in Aggrecan-deficient Patients With Recombinant Human Growth Hormone: 1-Year Response. Muthuvel G; Dauber A; Alexandrou E; Tyzinski L; Andrew M; Hwa V; Backeljauw P J Clin Endocrinol Metab; 2022 Apr; 107(5):e2103-e2109. PubMed ID: 34922359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]